| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |